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From the Editor’s Desk
LABRAD in 2017 begins on a thematic note. Our
focus this time is “Infectious Diseases”. Diagnostic
modalities play a central role in the therapy of
infectious diseases. With advancing technology,
the main focus remains on rapid turnaround times.
Diagnostic tests especially in our population should
be performed cost effectively with rapid delivery
of results in order to institute timely treatment.
In some infections, early diagnosis and treatment
prevent long-term complications or break the
continuity of transmission of the infectious agent. In
particular, diagnostic tests should come in handier
when clinical symptoms are not specific for a
particular infection (which occurs quite commonly).
Apart from this, testing for asymptomatic

infections, surveillance for hospital acquired
infections, evaluating response to treatment, and
detecting infections common to the developing
world are pre-requisites for any diagnostic test
employed for Infectious disease testing in Pakistan.
In this issue, we have covered topics which include
Chikungunya, Rubella, common bone and soft
tissue infections, Epstein Barr virus infection and
H.pylori to name a few. We have also added an
interesting quiz for our readers. Hope you will
enjoy the material and gain new insights in this
particular field of Medicine.
Dr Natasha Ali
Editor, LABRAD

Chikungunya
Ms Najma Shaheen
Clinical Microbiology

Chikungunya is an arbovirus, belonging to the
alphavirus family of bunyaviridae. It was first
documented in Tanzania in 1953. Since then
it has been reported from Europe (France and
Italy), Africa (Madagascar, Kenya), Americas
(United States, Mexico, and all of South America)
and Asia (India, Sri Lanka, China, Malaysia,
Thailand, Cambodia, and Yemen). Recently there
has been an outbreak in Malir district of Karachi,
Pakistan.
Due to its main symptom of severe joint pain, it was
named chikungunya, meaning “that which bends
up”. Other symptoms include muscle pain, headache
and rash is usually maculopapular, after the onset of
fever.
Usually the disease is self-limiting and patient
feels better within a week’s time. However in some
people joint pain may persist for several months.
Certain people are at higher risk of severe disease
with neurological or cardiac complications, like
newborns or elderly, and those who have underlying
comorbids, like heart disease, hypertension and
diabetes.

Transmission
Chikungunya is transmitted to humans by the
mosquito species Aedes aegypti and A. albopictus.
Both mosquitoes have white strips on black bodies and
legs and will be biting at any time of the day. Aedes
mosquito is also responsible for dengue infection.

Figure 1: Aedes aegypti (left) and A. albopictus (right) (Courtesy:
Google Images)

Diagnosis
l		
		
		
		
		
		

Serology: this diagnostic test includes the
detection of IgM and IgG. These tests can
be performed on serum or plasma using
enzyme-linked immunosorbent assay (ELISA),
indirect immunofluorescence, hemagglutination
inhibition, or neutralization techniques.
3
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IgM can be detected after the five days of
infection and it remains detectable up to
three months. The IgG antibodies can be
detected in convalescent samples (Figure 2) and
persist for years. The serologic tests are widely
used because they are more cost-effective than
other diagnostic tests in terms of disease
detection. They are also easy to perform. It may
show cross-reactivity with other alphaviruses
and minimally with flaviviruses like dengue.
Culture: Viral culture can detect virus within
three days of illness. However, it requires

		
		
l		
		
		
		
		
		

skilled personnel and well-equipped facilities
which may not be available everywhere.
Molecular diagnosis: RT-PCR consider as the
rapid diagnosis for Chikungunya infection as it
can detect viral RNA in blood as early as five
days after the symptoms appear. However, it
will not detect the virus efficiently after five
days of disease onset.

Testing of Chikungunya IgM by Elisa Method at
AKU
Chikungunya IgM Ab has been initiated in Clinical
Microbiology lab by ELISA method. This test is
performed twice a week.
Treatment and Prevention

Figure 2: Contribution of PCR and blood tests on the diagnosis of
Chikungunya, according to delay after test. 2

l		
		
l		
l		
		
		
		
		
		

Good intake of fluid, taking rest and pain killers
are the only treatment.
Vaccination is not available as yet.
Vector control is the main public health 				
strategy. Draining stagnant water and keeping
stored water covered will deplete the main
sites of mosquito breeding. Mosquito coils, bed
nets and mosquito repellents should be used to
avoid mosquito bites.

Difference between Chikungunya and Dengue
Virus:1
References:
Dengue

Character

Chikungunya

Causative agent

Dengue virus, (Flavivirus of Flaviviridea family)

Chikungunya virus (alphavirus of Togaviridea
family)

Vector

Aedes aegypti, A. albopictus

Aedes albopictus, A. aegypti

Incubation period

4-7 days

3-7days (range 1-12 days)

Disease duration

4-7 weeks

1-2 weeks, arthralgia may last for months

Symptoms

Fever, backache, large joint pain, headache, rash
usually on face and limbs, retro-orbital pain. No
arthritis

Fever, arthritis, pain in all joints, more prominent in small joints (worse in the morning),
headache, eye pain, generalized rash

Hemorrhage and shock

Common in Dengue Haemorrhagic Fever (DHF)
and Shock Syndrome (DSS)

Rare

Laboratory findings

Thrombocytopenia (<100,000/mm3), lymphopenia,
and neutropenia. Elevated liver enzymes (ALT,
AST); more with DHF

Mild thrombocytopenia (>100,000/ mm3),
lymphopenia, elevated liver enzymes (ALT,
AST)

Complications

Life threatening complications such as shock,
ARDS, multi-organ failure and severe haemorrhage

Upto 10% develop chronic joint pain. Rarely
neuroinvasive disease

1. Microbiology notes by Pratiksha Pokhrei, updated on 31st March 2016. Last accessed 21st Jan 2017. http://www.microbiologynotes.com/differences-between-dengue-andchikungunya/
2. Simon F. et al. French guidelines for the management of chikungunya (acute and persistent presentations). November 2014. Médecine et maladies infectieuses 45 (2015)
243–263
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Rapid Molecular Diagnosis of Chlamydia
Trachomatis (CT) and Neisseria Gonorrhoeae
(NG) Urethritis
Ms Najma Shaheen
Clinical Microbiology

Among the list of microorganisms involved in
sexually transmitted diseases, Chlamydia trachomatis
(CT) and Neisseria gonorrhoeae (NG) are the
most prevalent. Every year both CT and NG cause
around 351.7 million cases of human infection1,
associated with long term complications in both men
and women especially pregnant women and their
children. The complications include fetal growth
retardation, preterm birth, low birth weight, pelvic
inflammatory disease (PID) or ectopic pregnancy
and infertility. It can also cause perinatal diseases
such as conjunctivitis and pneumonia and sometimes
even infant death. For mothers who have been
infected with CT and NG there is also high incidence
of vertical transmission of HIV from mother to
children.
Neisseria Gonorrhoeae (NG)/Chlamydia
Trachomatis (CT) Diagnosis
l

Microscopy

Microscopic
examination
of urethral,
endocervical
swabs and
secretions is a
rapid test for
the detection of
NG in which
Intracellular gram negative diplococci.
they appear
Courtesy Google Images
as intracellular
gram negative bean shaped diplococci. Due to
lack of specificity, gram stain is not recommended
by the CDC for the detection of GC infection in
asymptomatic men and women at any site other than
the urethra.
Chlamydiae are non-motile bacteria that are located
intracellularly and require giemsa stain for their
detection. Giemsa stain is difficult to interpret and
requires skilled personnel, and therefore is not

readily available at all laboratories for chlamydia.
l

Culture

Culture can be relatively inexpensive and is highly
specific, but <100% sensitive when applied in
routine clinical practice due to the fastidiousness
of the Neisseria gonorrhoeae, which makes
successful growth less likely if isolation methods,
media, specimen transport are not optimal. Another
disadvantage is that a minimum of 72 hours is
required from specimen collection to the report of a
presumptive culture.
Specimens that can be used for the detection of
CT include endocervical swab, urethral swab, and
female genital tract tissue collected during surgery.
Culture has been the gold standard for Chlamydia in
the past, but there are difficulties in maintaining the
viability of organisms during transport and storage in
the diverse settings. Therefore, non-culture tests are
being used in diagnostic clinical laboratories.
The non-culture tests for C. trachomatis and N.
gonorrhoeae include
— Enzyme immunoassays (EIAs)
— Direct fluorescent antibody (DFA) tests
— Nucleic acid amplification testing (NAAT)
Despite culture being the gold standard, the
performance of Nucleic Acid Amplification Test
(NAAT) is overall better because its sensitivity and
specificity is higher for both CT and NG.
Rapid testing of CT/NG by Gene Xpert
introduced at AKU
l

l

Technique: This assay is a rapid real-time PCR
nucleic acid amplification test. The cartridgebased assay detects DNA of Chlamydia
trachomatis and Neisseria gonorrhoeae.
Turnaround time (TAT): This test has been
introduced in Clinical Microbiology Laboratory
at Aga Khan University Hospital. At this point
only urine samples are tested for CT/NG, while
5
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testing on vaginal and endocervical specimens
will be started later. Results are available within
90 minutes and it is performed 24 hours every
day. It may be used as a point of care test if
installed in clinics.

Samples Required for Testing
l

l

First-catch Urine for both males and females:
Unpreserved (neat) urine or collected using
the Urine Specimen Collection Kit provided by
manufacturer may be used
Endocervical /Vaginal swab specimens: Only
the manufacturer-provided Vaginal/ Endocervical
Specimen Collection Kit can be used for these
specimens, as it preserves patient specimens
during transport to the laboratory.

Figure 1: Courtesy: Google Images

Overview of Rubella Testing
Iffat Arman
Section of Chemical Pathology

Rubella is a member of togaviridae family and
humans remain the only natural host for this
virus. Rubella is also known as German measles
occurring throughout the world. Transmission
is typically through inhalation of infectious
aerosolized respiratory droplets and the incubation
period following exposure can range from 12 to
23 days. The prodromal stage includes malaise
and a low grade fever followed by characteristics
of lymphadenitis and finally a macular or
maculopapular rash. Primary infection during
pregnancy can pass transplacentally to the fetus
and can lead to fetal death or Congenital Rubella
Syndrome (CRS). Babies born with CRS typically
exhibit low birth weight, deafness, eye disease,
mental retardation and cardiac abnormalities. Rubella
infections are frequently mild or non-specific, making
the infection difficult to diagnose clinically. For these
reasons, pregnant women with an undiagnosed illness
with rash should be evaluated for the possibility of an
acute primary rubella infection. While the virus can be
cultured in vitro, serology remains the principal means
for establishing a clinical diagnose of acquired rubella
and congenital infections.
Interpretation of Rubella antibodies Positive
results
A primary infection induces an IgM and IgG
response. Within four to six months, IgM levels
6

becomes undetectable or very low. IgG decreases to
low levels but lasts indefinitely and confers lifelong
immunity. The secondary infection exhibits a rising
IgG antibody without significant levels of IgM.
Rubella IgM Positive
Immunoglobin IgM serological testing is the primary
diagnostic test use to confirm acute rubella infection.
An IgM test should not be used to determine rubella
immune status; IgM is used to diagnose acute and
recent rubella infection. Rubella IgM testing should
be performed on pregnant women who report
symptoms of rubella or susceptible pregnant women
who might have been exposed to rubella to rule out
acute or recent infection.
Rubella IgG positive
A positive rubella IgG antibody test indicates
rubella immunity (in pregnant females or vaccinated
children). However the presence of rubella IgG in an
infant after the decline of maternal antibodies (nine
months of age) and the absence of vaccination or
exposure to rubella will confirm CRS. Rubella IgG
antibody avidity can be used to distinguish between
recent infection and remote rubella infection, IgG
increases with time; this is known as maturation of
the immune response.
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Biomarkers for Sepsis
Dr Sibtain Ahmed
Chemical Pathology

Sepsis refers to the presence of a serious infection
that correlates with systemic and uncontrolled
immune activation. To date no gold standard test
is recognized for diagnosis of sepsis however
microbiological culture is taken as a reference
standard. Prompt diagnosis of sepsis is challenging,
with turnaround times surpassing the limits for rapid
diagnosis because microbiological culture results
take several days to come up so it is common clinical
practice to utilize available biomarkers that offer
rapid kinetics leading to an improved patient care
and facilitation. The various tests that are offered by
our clinical laboratory include:
Serum C - reactive protein (CRP)
CRP is a protein produced in response to infection
and it is extensively utilized in clinical practice to
diagnose and manage patients with sepsis. It is a
positive acute phase reactant whose synthesis in
the liver is up regulated by IL-6. The mechanism
of action in acute inflammation is that it may bind
the phospholipid components of microorganisms,
facilitating their removal by macrophages. Even
though its low specificity may be its primary
disadvantage as a biomarker of sepsis in adults, it is
commonly used to screen for early onset sepsis in
pediatrics. Normal concentration in healthy human
serum is usually lower than 10 mg/L whereas in
mild inflammation and viral infections it rises to
10–40 mg/L. Levels in active inflammation, bacterial
infection are in range of 40- 200 mg/L. Whereas in
severe bacterial infections and burns levels >200
mg/L have been recorded.
Serum Procalcitonin (PCT)
Procalcitonin is a pro hormone (peptide precursor)
of calcitonin that is secreted by parenchymal
cells, including hepatocytes, renal parenchymal
cells, adipocytes, and muscle cells in response to
bacterial toxins. Procalcitonin has also been used
to distinguish fungal and viral infections from
bacterial infections. During viral infections, PCT
levels are reported to remain at low levels, often
at concentrations found in healthy individuals. It
follows a rapid kinetics with levels rising in two
to four hours in response to bacterial infection. On

the other hand its level doesn’t show abrupt rise in
patients with viral infections. It possesses a half-life
of 22 to 26 hours, making it a superior marker in
term of kinetics compared with CRP and other acutephase reactants. However it faces certain limitation
that includes possible elevation in noninfectious
disorders, especially following trauma.
Furthermore PCT levels have been extensively used
to guide empirical antibacterial therapy in patients
with acute exacerbations of chronic bronchitis,
community-acquired pneumonia, and sepsis. PCT
also serves as a prognostic marker of sepsis as
PCT levels have been found to be associated with
increased mortality rates and correlate well with
severity scores (APACHE, SOFA, and SAPS). The
rapid elevation and sustainment of PCT levels in the
serum during infection makes it an ideal biomarker.
As a biomarker for bacterial infection, most studies
find PCT to be a useful and accurate biomarker.
Plasma Lactate
Hyper-lactatemia is characteristically present in
patients with severe sepsis or septic shock and may
be ancillary to anaerobic metabolism owing to hypo
perfusion or other multifaceted factors. The prognostic
value of elevated blood lactate levels has been well
recognized in septic shock patients, particularly if the
high levels continue. Given the high risk for septic
shock, all patients with elevated lactate >4 mmol/L
(36 mg/dL) are considered the early goal-directed
therapy zone irrespective of blood pressure. Mortality
is high in septic patients with lactate ≥4 mmol/L
making it a worthy prognostic marker as well.
Conclusion
Serum biomarkers discussed here have the potential
to diagnose, monitor, stratify and predict outcome in
sepsis. C-reactive protein is elevated in inflammatory
and infectious conditions and has long been used as a
biomarker indicating infection. Procalcitonin has more
recently been shown to better distinguish infection
from inflammation. Another important biomarker that
has specific relevance to distinguishing sepsis from
septic shock and predicting the prognosis of the latter
is the lactate level.
7
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Most Common Bone and Soft Tissue
Infections Seen in our Practice
Dr Nasir Ud Din and Dr Muhammad Usman Tariq
Histopathology

Introduction

Tuberculous Osteomyelitis

Soft tissue and bone infections can be caused
by either direct penetration of a pathogen or by
hematogeneous spread of the pathogen from the
initial site. In this article we shall discuss common
bone and soft tissue infections seen in our practice.

Tuberculous osteomyelitis is one of the most
common causes of bone infection seen in our
practice. The usual source of origin is from foci of
active visceral disease that are in the initial stages
of primary infection. The spine is affected in 4050 per cent of cases of tuberculous osteomyelitis,
and is followed in frequency by the hip and knee
joint bones in 25 per cent and 20 per cent of cases,
respectively. In the spine, 98 per cent of infections
are centered in the anterior column and the involved
level is usually located in the region of T6-L3,
leading to the formation of a gibbus or kyphosis.
The histologic features consist of the presence of
granulomas composed of aggregates of epithelioid
macrophages admixed with multinucleated giant
cells including Langhans type giant cells (Figure
1). Areas of caseous necrosis within a variably
inflammatory and frequently necrotizing background
are often seen. Acid-fast bacilli which are typically
beaded and bent and most often found either in the
necrotic zone or in the giant cells, but can be seen
anywhere in the granulomatous deposit on ZN stain.

Bacterial Infection of Bone
The most common form of infection of bone
(pyogenic osteomyelitis) is caused by hematogenous
spread of bacterial infection elsewhere in the body
such as a urinary tract infection or pneumonia.
Osteomyelitis also occurs after surgery, bone fracture
after road traffic accident and open wound over
bone in diabetics. In the initial stages of infection,
bacteria multiply, setting up a localized inflammatory
reaction and resulting in localized cell death. With
time, the infection becomes demarcated by a rim of
granulation tissue and new bone deposition.
Although no organisms are recovered in up to 50 per
cent of cases, when one is isolated, Staphylococcus
aureus is by far the most common agent accounting
for 80-90 per cent of all infections. Escherichia coli,
Klebsiella and Pseudomonas species are associated
with osteomyelitis in intravenous drug users and
genitourinary tract infection. Salmonella is involved
in osteomyelitis of patients with sickle cell disease.
Haemophilus influenza and group B streptococci are
involved in osteomyelitis of neonates.
In children, osteomyelitis usually affects the long
bones of extremities, including the femur and
humerus. Adults usually develop osteomyelitis
of vertebrae, fractured long bones and at hip
replacement. Osteomyelitis initially develops rapidly
and is usually accompanied by pain, fever, and joint
stiffness. Chronic osteomyelitis progresses slowly
and may be the result of a previous bone infection.
The histologic features of chronic infection also
include infarction of the bone with bony sclerosis,
as well as a mixture of inflammatory cells consisting
of macrophages, lymphocytes, plasma cells, and
neutrophils.
8

Figure 1: Granulomatous inflammation of bone with necrotizing
granulomas formation

Parasitic Osteomyelitis
Human echinococcal infection occurs across the
globe. It is more common in our population and
results from the ingestion of contaminated water and
food or handling live animals which act as definitive
hosts such as dogs, or working with their pelts.
The swallowed eggs hatch in the small intestine

MARCH 2017

and release minute hooked embryos which burrow
through the bowel wall and are then transported by
the bloodstream to various sites such as the lung,
liver, brain, skeletal muscle, and eyes. Involvement
of the skeletal system is rare and occurs in 0.2-4 per
cent of cases. Once the organisms reach their final
destination, they produce hydatid larval cysts. These
unilocular cysts are filled with fluid and lined by
an inner germinal membrane that produces brood
capsules (Figure 2). The inner wall of the brood
capsules facilitates an asexual budding process
that generates thousands of new larval tapeworms
(protoscolices) in daughter cysts. The hydatid cysts
can achieve large size (2 to 30 cm), have a thick wall
and contain clear or pale yellow fluid. The sites of
bone disease commonly include the spine, pelvis and
long bones. Once lodged within bone the hydatid
cyst fills the spaces between the bony trabeculae
and eventually results in their resorption and that of
the neighboring cortex such that it extends into the
adjacent soft tissues.

VOL. 43, ISSUE 1

fungi. Approximately 40 per cent of mycetomas
worldwide are eumycotic as opposed to
actinomycotic (i.e, caused by bacterial
actinomycetes). The disease is marked by
progressive destruction of soft tissue and nearby
anatomic structures.
Mode of infection is an inoculation of the
causative microorganism via small injuries of
the skin. The clinical correlate of both forms
of mycetoma is tumescence with abscesses,
painless nodules, sinuses and discharge. The
latter is commonly serous-purulent and contains
grains (filamentous granules) which can be
expressed for diagnostic purposes. Distinctive
for both eumycetoma and actinomycetoma,
are the formation of grains. Grains represent
microcolonies of the microorganism in vivo
in the vital tissue. Differentiation between
actinomycetoma and eumycetoma is important
because they respond to different treatments.
The diagnosis can be established only by
finding the “sulfar granules”. The granules of
both eumycetoma and actinomycetoma stain
with PAS and silver stain; those of eumycetoma
are composed of septate hyphae (4-5 µm),
whereas granules of actinomycetoma usually
consists of fine, branching filaments of bacillary

Figure 2: Hydatid cyst of bone. The acellular lamellated membranes are
filling the intertrabecular areas.
Eumycetoma (Fungal mycetoma)

Mycetoma (named because of the tumour-like
mass it forms) is a chronic granulomatous
disease predominantly involving feet (hence
also named Madura foot) and rarely can involve
the hands, back or shoulders. It is characterized
by localized infection of cutaneous and
subcutaneous tissues by actinomycetes or

Figure 3: Fungal mycetoma. There is massive tissue reaction with epithelioid cell granulomas together with grain which is a conglomerate of
septated and branched hyphae. Staining: PAS (Periodic-acid-Schiff) with
diastase reaction.

9
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forms (1 µm). Filaments of actinomycetoma are
gram positive, whereas the hyphae in grains of
eumycetoma are gram negative.
Fungal Osteomyelitis
Fungal osteomyelitis may occur as a component
of a multisystem infection or as an isolated
condition. It may evolve slowly and masquerade
other conditions such as tuberculosis, myeloma,
and metastatic disease. Fungal osteomyelitis
is a serious illness and is most virulent in
immunodeficient patients. Bone infection
occurs by hematogenous dissemination, direct
inoculation, and spread from a neighboring site
of disease. The clinical presentation and outcome
varies according to the specific pathogen, location
of the infection, and host factors. Invariably the
infection causes pain, localized swelling, bone
destruction with reactive changes, and a prominent
inflammatory reaction. Definitive diagnosis
usually requires identification of the organism in
tissue specimens or cultures (Figure 4).

PASD
Figure 4: Fungal infection of bone. Numerous branching hyphae are
present in necrotic background which is positive for PASD stain.

Overview of Epstein - Barr Virus Antibodies
Panel
Dr Tayyaba Hassan
Chemical Pathology

Epstein-Barr virus (EBV), also known as human
herpesvirus four is a member of the herpes virus
group and is the etiologic agent of infectious
mononucleosis. Other disorders due to EBV
infection include Burkitt lymphoma, nasopharyngeal
carcinoma and lymphoproliferative syndromes
especially in patients who have undergone renal or
bone marrow transplantation or those with AIDS.
Most people have been exposed to EBV by early
adulthood. Many people become infected with EBV
in childhood. EBV infections in children usually
do not cause symptoms, or the symptoms are not
distinguishable from other mild, brief childhood
illnesses. People, who get symptoms from EBV
infection, usually teenagers or adults, get better
in two to four weeks. However, some people may
feel fatigued for several weeks or even months.
Symptoms of EBV infection can include fever,
inflamed throat, swollen lymph nodes in the neck,
enlarged spleen, inflamed liver or rash. After you get
10

an EBV infection, the virus becomes latent (inactive)
in your body. In some cases, the virus may reactivate.
This does not always cause symptoms, but people
with weakened immune systems are more likely
to develop symptoms if EBV reactivates. EBV is
difficult to diagnose using one serological assay.
The EBV virus is composed of a double helix
of DNA. The DNA is surrounded by a protein
nucleocapsid (Figure 1). This nucleocapsid is
surrounded by a tegument made of protein, which in
turn is surrounded by an envelope containing both
lipids and surface projections of glycoproteins which
are essential to infection of the host cell.
Envelope protein
Envelope
Viral genome
Nucleocapsid
Viral tegument

Figure 1: EBV structure
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Diagnosis of an acute/ recurrent infection is best
accomplished by using a profile or panel of assays
which has three components:
• IgG Viral capsid antigen (VCA)
• IgM VCA
• IgG Epstein Barr nuclear antigen (EBNA )

The presence of VCA IgG antibodies indicates infection
sometime in the past. Antibodies to EBNA develop six
to eight weeks after primary infection and are detectable
for life. Specimens drawn too early during the course
of the disease may not contain detectable antibody to
Epstein-Barr virus (EBV). Another specimen drawn
one to two weeks later may be required.

Table 1: Interpretation of EBV antibody profile
EBNA-IgG

VCA-IgM

VCA-IgG

No previous exposure

Negative

Negative

Negative

Early primary infections

Negative

Positive

Negative

Acute infection

Negative

Positive

Positive

Past infection

Positive

Negative

Positive

Recovery stage

Positive

Positive

Positive

Diagnosis of Helicobacter Pylori Infection in
Developing Countries- Pros & Cons
Ms Syeda Kiran Zaidi
Clinical Microbiology

Helicobacter pylori infection is now recognized as
a worldwide problem. It is the most common cause
of chronic gastritis, peptic ulcer and it can also lead
to gastric cancer. Like all developing countries,
Pakistan also has high H. pylori prevalence, >85
percent (1). The most common route of H.pylori
infection is fecal- oral. Mostly, patients infected
with H.pylori are asymptomatic. When signs
and/or symptoms are present, they may include
nausea, vomiting, abdominal pain, heartburn,
diarrhea, hunger pangs in the morning, and halitosis
(bad breath). Diagnosis of H.pylori infection is
divided into two subgroups i.e. invasive and noninvasive tests. Invasive tests include endoscopy,
histopathology, culturing from tissue and rapid
urease test, whereas non-invasive tests include
stool antigen test, antibody response as a marker of
disease, and urea breath test.
Non-Invasive Tests
Stool antigen test detects active H.pylori infection,
independent of age, and has high sensitivity

and specificity; whereas, Anti-H. pylori IgG is a
supportive test as antibody titers remain high for
months or years even after treatment (Table 1).
For optimal results of stool antigen test, the patient
should be off antacids and proton pump inhibitors
(PPIs) for at least two weeks. Serological testing is
relatively inexpensive and it is widely available. In
a low-prevalence area a negative test has more value
than a positive test while in a high-prevalence area,
positive serology can reasonably be accepted as
positive. Urease breath test is also used as a common
non-invasive test; it is highly sensitive and specific.
One of the limitations is the presence of other
urease producing bacteria in the stomach, e.g. H.
heilmannii, which might lead to false positive results.
Moreover, acute bleeding and co-medication can lead
to false negative test results.
Invasive Tests
Among invasive test for H. pylori endoscopic biopsy
for histology remains the gold standard and has
a sensitivity of 95 percent and specificity of 100
11
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H. pylori seen on H&E. Image courtesy
http://www.pathologyoutlines.com/caseofweek/case157.htm

Alert: WHO has identified Helicobacter pylori
as one of the 12 priority organisms (Priority 2
HIGH) for anti-microbial resistance, i.e. resistant
to clarithromycin

percent but sensitivity may be reduced by the use of
PPIs, antibiotics, bismuth containing compounds and
test is also time-consuming and difficult to obtain.
H.pylori culture is not a routine procedure because
isolation of this microaerophilic organism from
gastric biopsy specimens takes five–seven days
and has an extremely low yield. Rapid urease test
on antral biopsy provide a simple, rapid, and costeffective method for the detection of H. pylori.
However, the value of these tests depends not only
on performance, but also on rapidity, making them a
practical tool for the endoscopist in decision-making
as to whether or not therapy should be prescribed.
False negative results can occur in patients taking
antisecretory drugs.

Table 1: Comparison of diagnostic tests for Helicobacter pylori infection
Test

Sensitivity

Specificity

Positive Predictive
Value

Comments

96%

95%

84%

• Non-invasive and inexpensive.
• Highly sensitive and specific before and after 		
treatment

85-92%

79-83%

64%

• Highly sensitive but does not accurately
identify active infection
• Not recommended after therapy

Urea Breath test

95%

96%

88%

• Preferred test for confirming eradication
• Not to be performed within 4 weeks of
antibiotic therapy
• Performed in clinic; variable availability

Biopsy

>95%

>95%

Culture

~30-40%

Stool
Antigen test
Serology
(IgG Ab)

Rapid
Urease test

>98%

• Gold Standard. Detection is improved by using
special stains for e.g. the Warthin Starry silver
stain, or Giemsa staining
• Highly specific; poor sensitivity if adequate 		
transport media are not available
• Expensive due to expertise and special culture
requirements, which may not be available

99%

99%

• Rapid and cheap. Post-treatment sensitivity 		
reduced.

Aga Khan University Hospital Clinical Laboratories offer H. pylori stool antigen, Anti-H. Pylori IgG and histopathology for diagnosis of this disease. However, there is a need to introduce rapid molecular tests for better
diagnosis of H. pylori infection and antibiotic resistance.
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Screening for Neonatal Infections with
TORCH Profile
Ms Nasreen Bano
Chemical Pathology

The TORCH profile is a group of tests used to
screen newborns and, sometimes, pregnant women
for certain infections that can cause birth defects
in a baby if the mother contracts them during the
pregnancy. The original concept of the TORCH
perinatal infections was to group five infections
with similar presentations, including rash and ocular
findings A TORCH profile can detect numerous
diseases, including herpes simplex, rubella,

cytomegalovirus and toxoplasmosis (Table 1).
A TORCH screen is typically performed when a
woman shows symptoms of any of these diseases
during pregnancy.
The profile aids in the diagnosis of both congenital
and acute acquired toxoplasmosis, cytomegalovirus,
rubella and herpes simplex virus by testing IgM
antibodies of all mentioned infections. The presence
of IgM antibodies indicates acute or recent infection.

Table 1: Clinical manifestations of congenital infections
Infection

Clinical Manifestations suggestive of specific congenital infections in the neonate

Toxoplasmosis

The most common finding is chorioretinitis
Hydrocephalus
Intellectual disability (mental retardation)
Intracranial calcifications (diffuse)
Otherwise unexplained mononuclear CSF pleocytosis or elevated CSF protein
Classic triad of congenital toxoplasmosis consists of chorioretinitis, hydrocephalus, and intracranial
calcifications

Rubella Virus
Infection
(German Measles)

Hearing impairment(Sensorineural hearing loss)
Cataracts, congenital glaucoma, pigmentary retinopathy
Cardiac defects (most commonly patent ductus arteriosus or peripheral pulmonary artery stenosis)
Radiolucent bone disease

Cytomegalo virus
(CMV) Infection

Microcephaly
Hepatoslpenomegaly
Periventricular intracranial calcifications
Thrombocytopenia
Sensorineural hearing loss
Preterm born infants infected with CMV after birth (especially via breastmilk) can have cognitive and
motor impairments later in life.

Herpes Simplex virus
(HSV) Infection

Most are asymptomatic at birth.
Mucocutaneous vesicles or scarring
Elevated transaminases
Conjunctivitis or keratoconjunctiitis
CSF pleocytosis.
3 patterns of ~ equal frequency with symptoms between birth and 4wks:
Localized to the skin, eyes, mouth (SEM)
Localized CNS disease
Disseminated disease (present earliest)
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Blood and Bone Marrow Changes in Viral
Infections
Dr Muhammad Shariq Shaikh
Haematology

Bone marrow is the primary site of haemopoiesis
throughout the life of an individual. A variety
of infections can involve bone marrow however
response of the bone marrow to infection is highly
variable, depending on presence of co-existing
disease, the age of the patient, nature (bacterial,
viral, parasitic or fungal) and duration of the
infection. In this article blood and bone marrow
changes in viral infections will be discussed.
Viral infections are usually associated with
lymphocytosis that sometimes exhibit atypical
features (Figure. 1). Infectious mononucleosis
caused by the Epstein-Barr virus (EBV)

Figure 1. Atypical Lymphocytes on Peripheral blood film (at 40x).

infection is characterized by the production of
large numbers of atypical lymphocytes. These
lymphocytes are characteristically pleomorphic,
have abundant basophilic cytoplasm and
prominent nucleoli. The similar picture may
also be a feature of other viral infections like
Cytomegalovirus (CMV) and hepatitis A as well
as toxoplasmosis and some hypersensitivity
reactions to drugs. In contrast, viruses that cause
lymphocytosis without significant atypical features
include Coxsackie virus, various adenoviruses
and Human immunodeficiency virus (HIV).
Haemoglobin concentration may be reduced
due to bone marrow suppression, haemorrhage
or haemolysis; conversely it may sometimes
be increased in patients with a severe capillary
leak syndrome in certain viral infections. A wide
range of viral haemorrhagic fevers are associated
characteristically with thrombocytopenia primarily
14

due to increased platelet consumption. Immune
mechanism in causation of cytopenias is wellknown, as in infections with Rubella, EBV, and
Chronic hepatitis C infections.
In addition to the features mentioned above, bone
marrow cytology in some infections particularly
by herpes viruses reveals haemophagocytosis.
In HIV-positive patients, Human Herpes Virus
8 (HHV8) infection may cause multicentric
Castleman’s disease. Another non-specific
feature is reactive increase in T-lymphocytes
and plasma cells. Bone marrow hypocellularity
with suppression of one or more lineages may
be seen in several viral infections including
CMV, HHV8, EBV, and Dengue fever. Erythroid
lineage may be hyperplastic with haemolysis
as in infectious mononucleosis whereas; in
parvovirus-induced pure red cell aplasia there
are prominent, very large pro-erythroblasts with
a striking lack of more mature cells. Rarely, in
immunologically competent people, persistent
infection can lead to chronic red cell aplasia. In
cases where thrombocytopenia is due to increased
platelet destruction, bone marrow shows normal
or increased number of megakaryocytes. Rarely,
platelets are visible in bone marrow macrophages.
Bone marrow histology provides better assessment
of cellularity as well as certain findings that may
not be recognized on examination of aspirate.
CMV infections may depict eosinophilic
intranuclear inclusions, albeit rarely these
inclusions are either present within granulomas
or interspersed in between haemopoietic cells.
In acute EBV infection, bone marrow may
exhibit gelatinous transformation or a diffuse
increase in reticulin. Reactive lymphoid nodules
in viral infection may be seen fairly commonly.
Examples include chronic hepatitis B, hepatitis
C and HIV infections. Where available, the
presence of various viruses can be confirmed
by immunohistochemistry using monoclonal
antibodies. Lastly, viruses have also been
implicated in causing lymphoproliferative
disorders; chronic hepatitis C infection
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can be complicated by the development of
low grade B-cell lymphoma. Whereas, in
patients with impaired immunity and X-linked
lymphoproliferative disorder, EBV infection
has been found associated with a spectrum
of lymphoproliferative disorders, including
lymphoma.
The peripheral blood and bone marrow response

to viral infections are largely non-specific and
similar changes occur in many other conditions,
including trauma, administration of growth factors,
carcinoma, Hodgkin and non-Hodgkin lymphoma
and autoimmune disorders such as systemic lupus
erythematosus. Therefore, high index of suspicion
along with careful morphologic examination of
both bone marrow aspirate and trephine biopsy is
required in patients with suspected viral infection.

Malaria
Dr Natasha Ali

Malaria is a parasitic infection transmitted through
the bite of infected female Anopheles mosquito.
It is a preventable and curable disease and many
countries are involved in the malaria eradication
programme. Sub-Saharan Africa has the highest
burden of disease. In 2015, 90 percent of malarial
infection and 92 percent of deaths related to
malaria occurred here. In Pakistan, the malaria
transmission period occurs post monsoon but
sporadic cases occur throughout the year.
Anopheles mosquitos are called “malaria vectors”.
There are, in total five species of malaria that
cause infection. Four of these cause infection
in humans while one is responsible for zoonotic
infection. These species are:

2. Plasmodium vivax: found mostly in Asia,
Latin America and few parts of Africa. It is
largely absent in West Africa where
individuals lack Duffy red blood cell
antigen – strong predictor of p.vivax red cell
invasion. Based on its distribution, it is
the most prevalent human malarial parasite.
Glucose-6-phosphate dehydrogenase
deficiency is associated with protection and
decreased parasite density in p.vivax
infections. P.vivax has a very strong
predilection to infect reticulocytes. It can
become latent in the liver, the stage known as
hypnozoites responsible for causing relapses
after months or years from the infection. The
stages commonly seen in peripheral smear are:

1. Plasmodium Falciparum: Found in tropical
and subtropical areas (e.g. Africa). P.
falciparum is responsible for complicated and
cerebral malaria. A parasitemia of more than
two percent requires red blood cell exchange
along with anti-malarials as part of treatment.
In the peripheral blood smear following forms
are seen routinely:
Trophozoite (p.vivax)

Trophozoites: thin delicate rings
in blood

Gametocyte showing presence of
“Laveran’s bib”

Schizont (p.vivax)

Gametocyte (p.vivax)
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3. Plasmodium ovale: Distributed primarily
throughout Sub-Saharan Africa. It has
also been reported from various islands of
Western Pacific. The diagnosis is based on its
characteristics on blood film and
differentiation from p.vivax. As p.vivax,
p.ovale also has a hypnozoite stage where the
parasites become suspended for many months.
After the sporozoites are introduced through
the bite of infected mosquitoes, these forms
invade the liver and within a single
parenchymal cell, the parasite matures within
ten days. Eventually, hundreds of merozoites
are produced which invade reticulocytes and
initiate the erythrocytic cycle. In the blood
smear, following stages are observed:

Gametocyte (p.ovale)

and humans, scientists at Osaka University
in Japan have discovered strains of p.malariae
in chimpanzees from Africa. Despite being
infected, the chimps have not shown
symptoms of disease. The stages identified on
peripheral blood smear include:
5. Plasmodium Knowlesi: Traditionally was
regarded as a rare disease, occurring
sporadically in humans. However, recent
findings of a large number of infected patients
in Malaysian Borneo; reports of human cases
in Thailand, Myanmar, the Philippines,
Singapore; and few reports of p. knowlesi
malaria in travelers to the Malaysian Borneo
suggest that p. knowlesi may be more
widespread among humans than perceived.
The infection occurs in long-tailed and pigtailed macaques that are present in forested
areas of Southeast Asia. P. knowlesi can be
transmitted from monkeys to humans by the
bite of an infected mosquito. In the blood
smear, the parasite is identified by:

Trophozoite (p.ovale)

Schizont (p.ovale)

Schizonts (p.knowlesi)

4. Plasmodium malariae: Infections caused
by p.malariae coincide with those caused
by p.falciparum. It is widely distributed in
Sub-Saharan Africa, Southeast Asia and
islands of Western Pacific. Cases have also
been reported in the Amazon basin of
South America. Not just limited to mosquitoes

Trophozoites (p.knowlesi)

Trophozoite (p.malariae) –
“Basket form”

16

Gametocyte (p.malariae) – rosette
pattern

The widely distributed malaria species causing
infection in Pakistan include p.falciparum and
p.vivax. Epidemiologically, Pakistan is classified
as a moderate malaria endemic country. P.vivax is
the major parasite species responsible for causing
more than 80 percent of the confirmed, reported
cases in the country.
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Film Array Multiplex PCR: A Syndromic
Diagnostic Approach
Dr Mohammad Zeeshan
Clinical Microbiology

Introduction
Early and reliable diagnosis of infectious diseases
is increasingly challenging due to changing
epidemiology in underlying diseases and use of
drugs affecting the immune system. Therefore,
throughout the globe, a paradigm shift has been
observed from conventional time-consuming,
laborious, and observer dependent tests towards
molecular diagnostics.
The role of microbiological evidence in infectious
disease diagnosis is vital in initiating the
appropriate antimicrobials, deciding patients’
prognoses, infection control and prevention
strategies, and duration of hospital stay.
Conventional tests such as microscopy and culture
for bacteria and fungus have limitations due to
low microbial count and longer incubation time.
Limited viral testing in routine clinical laboratory
often leads to under-diagnosis. Sometimes
chemical analysis of sample (e.g. CSF) is not
always reliable in delineating the causative agents,
rendering inconclusive especially after the use of
antibiotics.
Moreover, diversity of causative agents creates
a predicament for physicians due to overlapping
clinical findings. They face a dilemma of deciding
which test to order since a single diagnostic
platform is not usually available for a particular
presentation. This results in under diagnosis of
infections and compromised patient care.
A solution to this problem is molecular syndromic
diagnostic approach which uses broad test menu
on a small amount of a single sample. Film Array,
an FDA-cleared multiplex PCR system, is one
such platform approved for clinical use.
Principle
Multiplex PCR is a molecular biology technique
in which more than one target sequence can be
amplified by using multiple primer pairs in a
reaction mixture. The system is designed to be

used with comprehensive panels for different
syndromes. Each panel offers testing for sets
of causative organisms including bacteria,
viruses, yeast, parasites and/or antimicrobial
resistant genes in one go, with turnaround time
of a little over an hour. The following panels are
available which include the most common clinical
challenges these days:
l

l

l

l

Meningitis \ Encephalitis Panel (ME): For 14
most relevant ME-associated pathogens,
including bacteria, viruses and a yeast (See
Table).
Respiratory Panel: For a panel of 17 viruses
most commonly implicated in both upper and
lower respiratory tract infections, and three
bacteria which cannot be recovered on
routine culture: Bordetella pertussis,
Mycoplasma pneumoniae and Chlamydophila
pneumoniae.
Blood Culture Identification Panel: For
a comprehensive list of 24 pathogens and
three antibiotic resistance genes associated
with bloodstream infections.
Gastrointestinal Panel: tests for 22 common
gastrointestinal pathogens including viruses,
bacteria and protozoa that cause infectious
diarrhea.

The Clinical Laboratory of Aga Khan University
Hospital microbiology section plans to introduce the
Meningitis and Encephalitis panel (MEP) on Film
Array based testing of CSF samples for patients
with suspected meningitis and/or encephalitis.
17
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MICROORGANISMS

Meningitis\Encephalitis

Sample type
Sample volume
Hands-on time
Run time

Bacteria:
— Escherichia coli K1
— Haemophilus influenzae
— Listeria monocytogenes
— Neisseria meningitidis
— Streptococcus agalactiae
— Streptococcus
pneumoniae

Viruses:
— Cytomegalovirus (CMV)
— Enterovirus
— Herpes simplex virus 1 (HSV-1)
— Herpes simplex virus 2 (HSV-2)
— Human Herpes virus 6 (HHV-6)
— Human Parecho virus
— Varicella zoster virus (VZV)

Yeast:
— Cryptococcus 		
neoformans/gattii

CSF
200 µl
2 minutes
1 hour

How it works

Advantages

The film-array
reagent pouch
stores all the
necessary
reagents used
in sample
preparation,
reverse
transcription
and
amplification.
The hydrating
solution and
sample are added to the pouch which is then
loaded into the film array machine. The results
are analysed automatically and displayed on the
monitor as soon as the run is completed in the
form of a list of all the organisms “detected” and
“not detected” in the panel.

1. It has high sensitivity and specificity for each
of the organisms tested in the panel.
2. No precise measurement or pipetting,
therefore, no extensive hands-on technical
training is required in the entire procedure; its
use in Point of Care Testing (POCT) is 		
increasing.
3. Rapid identification of microorganism in onego with turn-around-time of one hour.
4. It is a closed system, minimizing chances of
contamination.
5. Although its one-time cost is high, rapidity
and reliability of test leads to shorter hospital
stay and lessen unnecessary procedures,
demonstrating its overall cost-effectiveness.
6. Identification of targeted organisms also
minimizes the use of inappropriate antibiotics
and other drugs, preventing emergence of
antimicrobial resistance and aiding
antimicrobial stewardship.
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World Rare Disease Day
Dr Lena Jafri
Section of Chemical Pathology

Karachi, Mar 10, 2017: ‘CME Seminar on
World Rare Disease Day’ was jointly organized
by the Department of Pathology and Laboratory
Medicine, Aga Khan University Hospital (AKUH)
and Pakistan Society of Chemical Pathology
(PSCP) at AKUH Karachi Pakistan. This CME
seminar was arranged to mark the occasion
of world rare disease day, which is observed
worldwide on the last day of February each year.
The objective was to create mass awareness about
rare diseases and to ensure that patients with rare
disease have access to treatment. We have been
organizing this CME since the last two years.
The theme for this year world rare disease day
was research; with the slogan: ‘with
research, possibilities are limitless!’.

AKUH. In comparison to PCR, MLPA amplifies
multiple genes in one run. Additionally MLPA
can detect carrier status of inherited disease.
Dr Salman Kirmani, Associate Professor, Chair
Department of Pediatrics and Child Health
discussed the importance of chromosomal
microarray for diagnosing rare disorders. He
explained that using this latest technology, it
is now possible for smaller and more complex
chromosome defects to be identified. Dr Kirmani
explained that this technology is able to identify
numerical abnormality however it cannot detect
structural defects or anomalies easily.

‘For most of the rare diseases, the
reality is that the answers to most
basic questions are missing. It is only
through research that identification
of previously unknown diseases and
understanding of diseases evolve.
Research leads to the development
of new innovative treatments and in
some cases a cure.’ said Dr Aysha
Panel of speakers in the question answer session at ‘CME Seminar World Rare Disease Day’
Habib Khan, Associate Professor and
Dr Lena Jafri, Assistant Professor Consultant
Section Head, Chemical Pathology, AKUH while
Chemical Pathologist at AKUH emphasized
delivering the welcome address. She added that
the importance of College of American
research is considered a key in bringing hope to
Pathologists (CAP) proficiency testing surveys
the millions of people living with a rare disease
as an educational and learning tool in her talk
across the world and their families. Dr Hafsa
‘Competency Based Educational Challenges
Majid Consultant Chemical Pathologist at AKUH
of Biochemical Genetics Laboratory’. She
gave an overview of rare diseases and highlighted
discussed few cases from CAP surveys and
the challenges faced in the diagnosis of these
highlighted its importance in reliability and
diseases in Pakistan. She shared the local data of
validity of patient reporting. ‘Inherited Metabolic
Inherited Metabolic Diseases (IMD) diagnosed
Disorders In Pakistan-reaching the unreached’
with locally available expertise at AKUH for
was an interesting talk by Dr Bushra Afroze,
organic acidurias & aminoacidopathies in highConsultant Pediatrician & Clinical Geneticist at
risk Pakistani pediatric population. During the past
AKUH, who specializes in treating IMD. She
few years many rare diseases have been reported
introduced the audience to her new venture of
with further additions to this never ending list,
tele health clinic between two clinical locations
explained Dr Majid.
in two different cities of the country. With real
life cases she explained how from a distance she
An enlightening talk on ‘Clinical Application of
has been managing patients with rare diseases.
Multiplex Ligation-dependent Probe Amplification
She emphasized that a strong liaison between
’ was given by Dr Zeeshan Ansar, Assistant
clinicians in a country like Pakistan with limited
Professor at the section of Molecular Pathology
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clinical expertise in IMD can be a pragmatic
approach to provide services to more patients at
their doorsteps.
Dr Farooq Ghani Associate Professor and
Service Line Chief Department of Pathology
and Laboratory Medicine in the closing remarks
appreciated the team work of pathologists and
pediatricians at AKUH in putting together this

CME seminar and in helping the children and
families with rare disease. We know that there is a
dearth of awareness regarding these rare diseases
and the need of the hour is to spread knowledge
about them in order to prepare ourselves in such
a way so that we can limit the dreadful effects of
such diseases. This CME was an attempt in this
regard with eminent speakers from Pathology &
Pediatrics.

Radiology Pathology Correlation
Dr Nasir Ud Din and Dr Dawar Khan
Histopathology and Radiology

A 15 year old boy presented with moderate localized
nocturnal pain of right distal thigh which was
relieved by aspirin. A plain radiograph showed an
oval shape lytic lesion along the long axis of the
bone surrounded by a thick dense rim of reactive
sclerosis that fades imperceptibly into surrounding
bone (Figure 1A). On lateral view, periosteal new
bone formation is noted (Figure 1B).

Figure 2A,B. Low and high power examination of biopsy showed sheets
of neutrophils.

Discussion
A Brodie abscess is a subacute osteomyelitis which
may persist for years before converting to a frank
osteomyelitis. Classically, this may present after
conversion as a draining abscess extending from
the tibia out through the shin. Occasionally acute
osteomyelitis may be contained to a localized area
and walled off by fibrous and granulation tissue. This
is termed as Brodie’s abscess.

Figure 1A,B. AP and Lateral view of distal femur shows lytic lesion
posteriorly with sclerotic margins and thick periosteal reaction.

A biopsy is done and histological examination
revealed neutrophilic abscess along with granulation
tissue formation (Figure 2A,B). The final diagnosis
after radiological-pathological correlation was
Brodie abscess.
20

Brodie’s abscess usually presents as a diagnostic
dilemma and clinically mimics various benign and
malignant conditions such as bone cyst, non-ossifying
fibroma, osteoid osteoma, and Ewing sarcoma. Also,
sometimes the radiological features are misleading.
Typically these present in children, more frequently
in boys. It usually occurs at the metaphysis of long
bones, distal tibia, proximal tibia, distal femur,
proximal or distal fibula, and distal radius. Most
frequent causative organism is Staphylococcus
aureus. Treatment is mainly surgery. If cavity is small
then surgical evacuation & curettage is performed
under antibiotic cover. If cavity is large then after
evacuation, packing with cancellous bone chips.
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Hepatitis C- Frequently asked Questions
Sibtain Ahmed
Section of Clinical Chemistry

l

Is it possible for someone to become infected
with HCV and then spontaneously clear the
infection?
Yes. Approximately 15%–25% of persons clear
the virus from their bodies without treatment and
do not develop chronic infection; the reasons for
this are not well known.

l

l

HCV RNA appears in blood and can be detected
as early as 2–3 weeks after infection.
l

How likely is HCV infection to become
chronic?

Can persons become infected with a different
strain of HCV after they have cleared the
initial infection?

l

Is there a hepatitis C vaccine?

l

No vaccine for hepatitis C is available. Research
into the development of a vaccine is under way
l

l

How soon after exposure to HCV can antiHCV be detected?
HCV infection can be detected by anti-HCV
screening tests (enzyme immunoassay) 4–10
weeks after infection. Anti-HCV can be
detected in >97% of persons by 6 months after
exposure.

Can a patient have a normal liver enzyme
(e.g., ALT) level and still have chronic
hepatitis C?
Yes. It is common for patients with chronic
hepatitis C to have liver enzyme levels that go
up and down, with periodic returns to normal or
near normal levels. Liver enzyme levels can
remain normal for over a year despite chronic
liver disease.

How soon after exposure to HCV do
symptoms appear?
In those persons who do develop symptoms, the
average time period from exposure to symptom
onset is 4–12 weeks (range: 2–24 weeks).

Under what circumstances might a falsenegative anti-HCV test result occur?
Persons with early HCV infection might not yet
have developed antibody levels high enough
that the test can measure. In addition, some
persons might lack the (immune) response
necessary for the test to work well. In these
persons, further testing such as PCR for HCV
RNA may be considered.

Yes. Prior infection with HCV does not protect
against later infection with the same or different
genotypes of the virus. This is because persons
infected with HCV typically have an ineffective
immune response due to changes in the virus
during infection. For the same reason, no
effective pre- or post-exposure prophylaxis (i.e.,
immune globulin) is available.
l

Under what circumstances is a false-positive
anti-HCV test result likely?
False-positive anti-HCV tests appear more often
when persons at low risk for HCV infection (e.g.,
blood donors) are tested. Therefore, it is
important to follow-up all positive anti-HCV
tests with a RNA test to establish current
infection.

HCV infection becomes chronic in
approximately 75%–85% of cases.
l

How soon after exposure to HCV can HCV
RNA be detected by PCR?

l

Should HCV-infected persons be restricted
from working in certain occupations or
settings?
CDC’s recommendations for prevention and
control of HCV infection specify that persons
should not be excluded from work, school, play,
child care, or other settings on the basis of their
HCV infection status. There is no evidence of
HCV transmission from food handlers, teachers,
21
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or other service providers in the absence of
blood-to-blood contact.
l

Should a woman with HCV infection be
advised against breastfeeding?
No. There is no evidence that breastfeeding
spreads HCV. However, HCV-positive mothers
should consider abstaining from breastfeeding if
their nipples are cracked or bleeding.

l

When should children born to HCV-infected
mothers be tested to see if they were infected

at birth?
Children should be tested for anti-HCV no
sooner than age 18 months because anti-HCV
from the mother might last until this age. If
diagnosis is desired before the child turns 18
months, testing for HCV RNA could be
performed at or after the infant’s first well-child
visit at age 1–2 months. HCV RNA testing
should then be repeated at a subsequent visit,
independent of the initial HCV RNA test result.
Reference: CDC - Hepatitis C FAQs for Health Professionals; URL:
https://www.cdc.gov/hepatitis/hcv/hcvfaq.htm )

Details Of Therapeutic Drug Monitoring Of Antibiotics
Dr Syed Bilal Hashmi, Chemical Pathology
Drug

Time of Sample
Collection

Gentamicin

Peak testing:
Exactly 1 h after start
of infusion of 3rd
dose, or 1st dose in
critically ill patients
Trough: predose

Clinical Inofrmation and Uses
l

l

l

Vancomycin Trough
vancomycin
concentrations are
the most accurate and
practical method to
guide Vancomycin
dosing. Serum trough
concentrations should
be obtained prior to
the fourth or fifth dose

l

l

Amikacin
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Peak: Exactly 1 h
after start of infusion
of 3rd dose, or 1st
dose in critically ill
patients) Trough:
Predose

l

l

Therapeutic Ranges

Toxicity Signs and
Symptoms

Gentamicin is an antibiotic used to treat
life-threatening blood infections
caused by gram-negative bacilli,
particularly Citrobacter freundii ,
Acinetobacter species, Enterobacter
species, Escherichia coli, Klebsiella
pneumoniae, Proteus mirabilis ,
Providencia stuartii, Pseudomonas
aeruginsa, and Serratia species.
Gentamicin levels are tested for
monitoring adequacy of drug clearance
during gentamicin therapy
Goal levels depend on the type of
infection being treated.

Adults Multiple
daily dose
Peak: 4-10 ug/ml
Trough: 1-2 ug/ml

l
l
l
l

Adult Once daily
dose
Trough <1 ug/ml

l

Dizziness
Vertigo
Ataxia
Meniere 		
disease-like
syndrome
Nephrotoxicity.

Vancomycin is an antibiotic used to treat
infections caused by gram-positive
organisms that are resistant to betalactam antibiotics, such as methicillinresistant staphylococci (MRSA),
Staphylococcus viridans group,
penicillin/cephalosporin-resistant
Streptococcus pneumoniae, and
penicillin/ampicillin-resistant
Enterococcus species.
Gentamicin levels are tested for
monitoring adequacy of drug
concentration during vancomycin
therapy

Therapeutic
concentration:
>10 ug/ml
Trough: 15-20 ug/ml

l
l

Nephrotoxicity
Ototoxicity

Amikacin is an aminoglycoside used to
treat severe blood infections by
susceptible strains of gram-negative
bacteria.
Amikacin levels are tested for
monitoring adequacy of blood
concentration during Amikacin therapy

Amikacin-Once
daily dose
Trough: <1.0 ug/ml
Peak: 56-64 ug/ml

l
l

Ototoxicity,
Nephrotoxicity

Pediatrics trough
conc.: <2ug/ml

Amikacin-Multiple
daily dose
Trough: 5-10 ug/ml
Peak: 15-30 ug/ml
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